Matsushima Hajime, Kuroki Tamotsu, Adachi Tomohiko, Kitasato Amane, Hirabaru Masataka, Hidaka Masaaki, Soyama Akihiko, Takatsuki Mitsuhisa, Eguchi Susumu
Department of Surgery, Nagasaki University, Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan.
Department of Surgery, Nagasaki University, Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan.
Pancreatology. 2014 Nov-Dec;14(6):530-5. doi: 10.1016/j.pan.2014.09.007. Epub 2014 Sep 30.
BACKGROUND/OBJECTIVES: Laparoscopic spleen-preserving distal pancreatectomy (LSPDP) for low-grade malignant pancreas tumors was recently demonstrated. Although the procedure with splenic vessel preservation (SVP) is optimal for LSPDP, SVP is not always possible in patients with a large tumor or a tumor attached to splenic vessels. This study aimed to analyze the safety of two procedures: LSPDP without SVP, known as the Warshaw technique (lap-WT), and LSPDP with SVP (lap-SVP).
Seventeen patients who underwent a lap-WT and seven patients who underwent a lap-SVP were investigated retrospectively.
The median follow-up duration was 45 (range 17-105) months. In the lap-WT and lap-SVP patients, the sizes of the tumors were 5 (1.3-12) and 1.5 (1-4) cm; the operative times were 304 (168-512) and 319 (238-387) min; the blood loss was 210 (5-3250) and 60 (9-210) gr; the length of the postoperative hospital stay was 15 (8-29) and 18 (5-24) days; the peak platelet counts were 37.2 (14.6-65.2) and 26.4 (18.8-41) × 10(4)/μL, and splenomegaly was observed in 10 (59%) and three (43%) patients, respectively. In both procedures, there was no local recurrence. In the lap-WT group, splenic infarctions were seen in four (24%) patients and perigastric varices were seen in two (12%) patients. All of these patients were observed conservatively.
Both the lap-WT and lap-SVP were found to be safe and effective, and in cases in which the tumor is relatively large or close to the splenic vessels, lap-WT can be used as the more appropriate procedure.
背景/目的:近期已证实腹腔镜保留脾脏的远端胰腺切除术(LSPDP)可用于治疗低级别恶性胰腺肿瘤。尽管保留脾血管(SVP)的手术方式对LSPDP最为理想,但对于肿瘤较大或肿瘤附着于脾血管的患者,SVP并非总是可行。本研究旨在分析两种手术方式的安全性:不保留SVP的LSPDP,即Warshaw技术(lap-WT),以及保留SVP的LSPDP(lap-SVP)。
回顾性研究了17例行lap-WT的患者和7例行lap-SVP的患者。
中位随访时间为45(范围17 - 105)个月。lap-WT组和lap-SVP组患者的肿瘤大小分别为5(1.3 - 12)cm和1.5(1 - 4)cm;手术时间分别为304(168 - 512)分钟和319(238 - 387)分钟;失血量分别为210(5 - 3250)克和60(9 - 210)克;术后住院时间分别为15(8 - 29)天和18(5 - 24)天;血小板计数峰值分别为37.2(14.6 - 65.2)×10⁴/μL和26.4(18.8 - 41)×10⁴/μL,脾肿大分别见于10例(59%)和3例(43%)患者。两种手术方式均无局部复发。lap-WT组中,4例(24%)患者出现脾梗死,2例(12%)患者出现胃周静脉曲张。所有这些患者均采取保守观察。
lap-WT和lap-SVP均被发现安全有效,在肿瘤相对较大或靠近脾血管的情况下,lap-WT可作为更合适的手术方式。